Please login to the form below

Not currently logged in
Email:
Password:

Kantar’s Gracie van Kemenade appointed quantitative director at Insight Research Group

Paul O’Meara also joins as regional head of syndicated studies

Gracie van Kemenade has left Kantar Health to join Insight Research Group as quantative director.

She is joined at the market research company by fellow new recruit Paul O'Meara, who has been appointed regional head of syndicated studies.

Van Kemenade was previously global account lead for major pharmaceutical companies at Kantar, and will work across the whole research team in her new role at Insight.

Her main focus will be to work with Insight's existing quantitative research team and apply her experience in the development of new proprietary quantitative research methodologies.

In addition, van Kemenade has experience in market landscape, target product profiling, patient record studies, launch tracking and brand equity research.

Grace van Kemenade - Insight Research GroupPaul O'Meara - Insight Research Group
Gracie van Kemenade and Paul O'Meara

O'Meara was most recently at Ipsos Healthcare where he was head of syndicated studies for the Asia-Pacific region.

Nicola Cowland, joint CEO at Insight Research Group, said of O'Meara and van Kemenade: “Their recruitment is the latest step in bolstering Insight's quantitative research capabilities, developing innovative and valuable new research offerings and affirming our presence as a leading global player in quantitative, qualitative and digital market research in the healthcare sector.”

21st August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics